Typicality: | 0.503 |
Saliency: | 0.213 |
with clinical research organizations | 8 | other |
up to termination | 3 | temporal |
with cros | 2 | other |
expense → be incurred under → agreement | 8 |
expense → be incurred under → this agreement | 3 |
negative | neutral | positive |
0.316 | 0.655 | 0.029 |
Raw frequency | 11 |
Normalized frequency | 0.213 |
Modifier score | 1.000 |
Perplexity | 226.793 |